ACV meeting #23, 30 July 2021

The meeting of the Advisory Committee on Vaccines (ACV).

The committee provided advice on one application to register a new vaccine, and one application to extend the indications of the vaccine.

The committee provided advice on one matter relating to pharmacovigilance.

• COVID-19 vaccine AstraZeneca [now, Vaxzevria] and Guillain Barre Syndrome

Members

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.